Low-dose aspirin reduces morbidity and mortality in pregnant women at high-risk for preeclampsia

Evidence-Based Nursing

Volumn 18, Issue 3, 2015, Pages 71-

  Bujold, Emmanuel ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

FEMALE; HUMAN; PRE-ECLAMPSIA; PREGNANCY;

ASPIRIN; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY;

EID: 84936069345     PISSN: 13676539     EISSN: 14689618     Source Type: Journal    
DOI: 10.1136/ebnurs-2014-101915     Document Type: Note

References (6)

1. Crandon AJ, Isherwood DM. Effect of aspirin on incidence of preeclampsia. Lancet 1979;1:1356.
2. Beaufils M, Uzan S, Donsimoni R, et al. Prevention of preeclampsia by early antiplatelet therapy. Lancet 1985;1:840-2.
3. Brosens I, Pijnenborg R, Vercruysse L, et al. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol 2011;204:193-201.
4. Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402-14.
5. Roberge S, Nicolaides KH, Demers S, et al. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 2013;41:491-9.
6. Poon LC, Nicolaides KH. First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn 2014;34:618-27.